Acrivon Therapeutics Employee Directory

Acrivon Therapeutics corporate office is located in 480 Arsenal Way Ste 100, Watertown, Massachusetts, 02472, United States and has 51-200 employees.

Employees by Department

Departments

Number of employees

Engineering & Technical

12

Medical & Health

11

Operations

11

C-Suite

3

Legal

2

Finance

2

Marketing

2

Key Employees of Acrivon Therapeutics

Acrivon Therapeutics Global Presence

globalPresence illustration
North America11-50
Europe1-10

Index of contact profiles from Acrivon Therapeutics

Hundreds of professionals searching for Acrivon Therapeutics have connected with key decision-makers. Join them?
Contact Name
Contact Info
Job Title
HQ Location
123

Former Employees at Acrivon Therapeutics

Explore people who held key positions, contributed to Acrivon Therapeutics's success, and advanced their careers.

People from Similar Companies in the Manufacturing Industry Located in Massachusetts, United States

Frequently Asked Questions Regarding Acrivon Therapeutics Employees

How many employees does Acrivon Therapeutics have?
Acrivon Therapeutics has 51-200 employees
Who is the CFO of Acrivon Therapeutics?
Acrivon Therapeutics’s CFO is Rasmus Holm-Jorgensen
Who are Acrivon Therapeutics key employees?
Some of Acrivon Therapeutics key employees are Rasmus Holm-Jorgensen, Mary-Alice Miller
Where is Acrivon Therapeutics located?
Acrivon Therapeutics’s headquarters are located at 480 Arsenal Way Ste 100, Watertown, Massachusetts, 02472, United States
How do I contact Acrivon Therapeutics?
Acrivon Therapeutics Contact Info: Phone number: (617) 207-8979 Website: www.acrivon.com
What does Acrivon Therapeutics do?

Acrivon is focused on developing best-in-class targeted therapies to enhance the lives of cancer patients through its proprietary AP3 precision medicine platform. The company aims to revolutionize precision oncology by accurately matching drug candidates with patients whose tumors are predicted to be sensitive, thereby improving therapeutic outcome... s. Acrivon's pipeline includes advanced programs targeting DNA Damage Response and other critical cancer pathways, with its lead candidate ACR-368 currently in phase 2 clinical development. The company seeks strategic partnerships for co-development and is committed to addressing the world's most pressing cancer challenges.Read More

Is Acrivon Therapeutics a public company?
Yes, Acrivon Therapeutics is a public company and is traded under the symbol ACRV
See more information about Acrivon Therapeutics Employees

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.